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Small Molecule Recognition of Mephedrone using An Anthracene 
Molecular Clip  
K. Kellett,a J. H. Broomeb, M. Zloha, S. B. Kirtona, S. Fergusa, U. Gerharda, J. L. Staira* and K. J. 
Wallace*b  
An anthracene molecular probe has been synthesised and shown 
to target mephedrone, a stimulant drug from the cathinone class 
of new psychoactive substances (NPS). A protocol has been 
developed to detect mephedrone via the probe using NMR 
spectroscopy in a simulated street sample containing two of the 
most common cutting agents, benzocaine and caffeine.   
There is continuing interest in utilising host-guest recognition in 
different disciplines, for example, biological transportation within 
cells1, the materials world,2 and forensic science, which is now 
employing host-guest chemistry in portable devices for rapid and 
onsite identification of illicit substances.3 At present, there is a lack 
of rapid screening approaches for new drugs of abuse, a necessity 
for both law enforcement and healthcare workers. Although a 
number of approaches have been investigated4 there remains a 
need to improve selectivity over chemical analogues and common 
cutting agents. 
New psychoactive substances (NPS), also referred to as designer 
drugs or ‘legal highs’, are newly available substances not controlled 
by the United Nations drug conventions but may cause serious 
negative health effects. Cathinones, such as mephedrone and 
flephedrone (Fig. 1A), are stimulants and one of the most abused 
class of NPS.5 Due to their lipophilic nature, they can easily pass 
through the blood brain barrier; thereby, stimulating the central 
nervous system by releasing dopamine and inhibiting the re-uptake 
of epinephrine, norepinephrine and serotonin.6 Mephedrone is of 
particular concern due to its negative health implications and 
continued popularity despite efforts to control the substance.5  
A major challenge in the field of drug detection is the 
preferential recognition of a specific NPS over related analogues 
possessing similar organic frameworks. For example, flephedrone 
differs from mephedrone by only one 4-fluoro motif, while 
methamphetamine differs by a carbonyl and tolyl moiety (Fig. 1A). 
These small structural differences have potential to significantly 
impact binding to a host molecule. The work presented in this study 
demonstrates that the concerted effort of multiple interaction sites 
between an anthracene molecular ‘clip’ and the NPS mephedrone 
results in a molecular probe that preferentially targets mephedrone 
over related substances.   
 
 
Fig. 1. Structures of mephedrone, and related chemical analogues (A) and 
cutting agents (B). 
There is a plethora of molecular probes utilising the concept of 
host-guest chemistry7 for the detection of cation,8 anion,9 neutral10 
and simultaneous cation-anion11 species. At present, there are no 
studies investigating small molecule recognition for mephedrone or 
any NPS for that matter. It is known that amphetamines can 
interact with proteins via non-covalent interactions, in particular, π-
π stacking and hydrogen bonding interactions.12 Examination of the 
Brookhaven Protein DataBank13 was carried out to identify high-
quality protein-ligand complexes between receptors, and drugs of 
abuse/common adulterants/endogenous psychoactive substances 
(i.e. dopamine and serotonin) similar to mephedrone. These were 
used to develop a consensus pharmacophore of mephedrone-
receptor binding to support host molecule selection (ESI Fig. S1 and 
S2). With this in mind, a molecular probe was designed that utilised 
these interactions to bind mephedrone. The rigid anthracene 
scaffold was chosen to enable - stacking with aromatic 
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functionalities on the mephedrone as well as to provide an organic 
backbone and incorporate hydrogen-bonding motifs (thiourea 
moieties),14 interactions demonstrated as being important by the 
pharmacophore analysis (see ESI). Anthracene analogues have a 
planar structure complemented by a conjugated  network, making 
them excellent fluorophores, due to their photoluminescence 
properties.9 These unique photophysical and structural properties 
allow the anthracene moiety to double as a signalling unit, while 
being an integral part of the chemosensor’s rigid scaffold. The guest 
is anticipated to bind within the cleft formed by the anthracene and 
the thiourea arms, which are functionalized in the 1 and 8 position 
of the anthracene unit. Thus, compound 2 was prepared by reacting 
1,8-diaminoanthracene with two equivalents of 
benzylisothiocyanate in ethanol (see ESI). The solid was filtered, 
dried and washed with ethanol to afford the desired molecular 
probe 2 in 40% yield (scheme 1). 
 
 
Scheme 1. Synthesis of molecular probe 2. 
In order to scrutinize the binding affinity of probe 2 towards 
mephedrone, 1H-NMR spectroscopy was used extensively to 
determine which hydrogen atom environment on the molecular 
probe was perturbed upon the addition of the drug. As it is well 
known that thioureas are excellent binding motifs for anions, the 
free amine form of mephedrone was utilized to exclude any 
interaction between the counter-anion (Cl-) and the host.15 Once 
this was achieved aliquots of mephedrone in acetone were added 
to a 0.02 moldm-3 solution of probe 2 in acetone-d6. When adding 
mephedrone, the two NH protons on the thiourea group observed 
at 9.87 and 8.29 ppm were significantly shifted down-field (ESI 
Table S2 and Fig. 2). These chemical shift changes can be 
rationalised by close contact of a single hydrogen-bonding 
interaction between the carbonyl group on the mephedrone 
molecule and the hydrogen atom on one of the NH groups of the 
thiourea. Additionally, the C(9)H and the C(10)H, 8.78 and 8.67 ppm 
respectively, of the molecular probe’s scaffold also showed 
chemical shift changes. This suggests these hydrogen atoms are also 
influenced by the drug being bound in close proximity. Neutral 
molecule detection can be difficult with molecular ‘clips’ as there is 
often a high degree of flexibility where a multitude of non-covalent 
interactions are required to work in a concerted fashion to 
overcome any entropic considerations. However, an advantage of 
neutral guest recognition is that the guest has an organic 
framework, whereby chemical shift changes of the guest can also 
be used to aid understanding of the close contacts. In addition to 
chemical shift changes seen on the host, there were also 
noteworthy changes seen for mephedrone from the methine 
centre, two methyl groups, and tolyl methyl moiety (ESI Fig. S5). 
The methine and two methyl groups are in close proximity to the β-
carbonyl and amine functionalities, which undergo hydrogen 
bonding with the host. This causes a decrease in electron density 
around these groups on mephedrone, which results in downfield 
1H-NMR shifts. Conversely, the tolyl methyl experiences an up-field 
shift. Interestingly, the sigmoidal behaviour seen in the binding 
isotherm (Fig. 2) suggests that cooperativity is occurring. Whereby, 
the three non-covalent interactions (2  CH and NHN) with 
compound 2, facilitate the NHOC binding event in a cooperative 
manner. This is reasonable as these interactions are missing in the 
model compound, whereby no chemical shifts are seen (Fig 2, 
entries E and F)  
The choice of analogous guests was important to this study in 
order to establish selectivity between related chemical analogues 
(Fig. 1A) and typical adulterants (Fig. 1B) found in ‘street’ samples.16 
Each compound from Fig. 1 was added to a 0.02 moldm-3 acetone-
d6 solution of probe 2 (see ESI). The mephedrone analogue (1-(p-
tolyl)propan-1-one) and methamphetamine were evaluated in 
order to systematically isolate interaction from the carbonyl and 
amine functional groups on the guest. The addition of these two 
substances showed only subtle shift changes (ESI Fig. S6 and Fig. S7 
respectively), while flephedrone showed interaction but still to a 
lesser degree than mephedrone (Fig. 2 and ESI Fig. S8). This 
suggests that the host interacts preferentially with cathinone-like 
structures (i.e. requiring both a carbonyl and amine on the guest). 
The adulterants tested (lidocaine, acetaminophen, benzocaine and 
caffeine) resulted in no proton shift changes on the host further 
supporting the need for a -ketoamine arrangement to induce 
interactions (ESI Fig. S11-S14). A plot of the N(1)H signal versus 
concentration of mephedrone and analogues for titration 
experiments against probe 2 shows that mephedrone gave the 
largest chemical shift change,  2 ppm, when compared to the 
other compounds (Fig. 2 bottom). Upon closer inspection of the 
NMR spectra, the addition of mephedrone, flephedrone, or 
methamphetamine gave rise to new 1H-NMR signals. We believe a 
pericyclic cycloaddition reaction is occurring in the C(9)H and 
C(10)H position on the anthracene ring, commonly seen in other 
anthracene systems.17 As a consequence of the 4+4 cycloaddition 
it is difficult to obtain reasonable K values by least-square 
regression. 
To investigate whether two thiourea pendant side arms are 
necessary in order to establish the probe-drug interaction, model 
compound 3 (1-benzyl-3-phenylthiourea) was also synthesised and 
isolated (see ESI). The same set of 1H-NMR titration experiments 
were carried out with the two cathinones. There were minimal 
chemical shift changes observed from compound 3 in the presence 
of mephedrone or flephedrone (ESI Fig. S15 and S17). Therefore, it 
is reasonable to assume that both thiourea functional groups are 
required for binding the drug in a concerted fashion and 
highlighting the importance of the chelate effect with probe 2 (see 
DFT discussion). As there is no anthracene moiety, a pericyclic 
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cycloaddition was not observed supporting the claim that a 
cycloaddition reaction is occurring with probe 2.  
It is known that solvent molecules often compete with the 
analyte.  Therefore, mass spectrometry studies were carried out to 
support the formation of the host-guest complex, as solvent 
molecules are not normally a factor in gas phase MS. Samples were 
prepared in HPLC grade acetone, in which 10 equivalents of the 
free-amine drug were added. The mass spectra of probe 2 was 
analysed in the presence of mephedrone and flephedrone, giving 
ESI-MS (+’ve) m/z = 685 [(2)mephedrone+H]+, and m/z = 689 
[(2)flephedrone+H]+ (ESI Fig. S19 and S20). To confirm that the 
probe 2-drug mass signal was not an artefact, deuterated water was 
added to the sample to show an increase in the mass due to the 
exchange of the labile protons with deuterium. It is reasonable to 
assume that the aromatic  systems certainly aids binding in the gas 
phase, as there is no competing solvent molecules. This is also 
supported by MS-MS experiments, whereby the 2-mephedrone 
host-guest complex fragments into the free-drug and probe 2 upon 




Fig. 2. (Top) Partial 1H-NMR spectra showing titration of probe 2 with the 
addition of mephedrone; (*) is suspected cycloaddition product. (Bottom) 
Chemical shift changes observed for the NH(1) signal, upon the addition of 
(A) mephedrone, (B) flephedrone, (C) methamphetamine, (D) 1-(p-
tolyl)propan-1-one (mephedrone analogue), (E) and (F) compound 3 upon 
the addition of mephedrone and flephedrone, respectively. 
Molecular modelling calculations were carried out to rationalize 
the change of NMR chemical shifts observed in the solution phase. 
The minimum energy conformations were generated for probe 2 
alone, mephedrone and flephedrone, and relevant host-guest 
complexes using conformational searching implemented in 
Hyperchem 8.10 and OPLS force field (ESI Fig. S21 to S25). Selected 
conformations were optimized using density functional theory (DFT) 
calculations (B3LYP 6-311++G(2d,2p) in Orca). Probe 2 had two low 
energy conformations in the gas phase, which were taken forward 
for analysis of the bound complexes using DFT calculations. The 
proposed geometry of the host-drug interaction for probe 2 is 
supported by the DFT calculations (Fig. 3). This optimised structure, 
which shows mephedrone bound within the cleft of probe 2 via an 
array of hydrogen bonding interactions18 and a π-π interaction,19 
further supports the observed NMR chemical shift changes.  
Another interesting feature is the trans-cis rotamer of the thiourea 
group, typically seen in solution, observed in the solid state and 
supported by theoretical calculations, which suggests that trans-cis 
is the preferred rotamer, unlike the analogous urea group which is 
rarely seen in the trans-cis fashion.20  
The interaction energies were calculated for probe 2 with both 
mephedrone and flephedrone based on the minimum energy 
conformation of the complexes (see ESI). Mephedrone positioned 
within the binding pocket of probe 2 suggested the formation of 
two hydrogen bonds with a favourable interaction energy of -2.88 
kcalmol-1 (Fig. 3). Flephedrone, a closely related mephedrone 
analogue, was found to bind to probe 2 outside of the binding 
pocket, leading to just one hydrogen bond forming and an 
interaction energy of -7.82 kcalmol-1. Interaction energies indicated 
that there is a clear preference for the lowest energy conformation 
for each complex. To ensure that the minimum conformation of 
both drugs was achieved, the cathinones were studied in their 
respective binding positions, i.e. mephedrone was positioned to 
bind to probe 2 outside of the binding pocket and vice versa. The 
interaction energy of mephedrone bound outside of the pocket was 
14.67 kcalmol-1, while flephedrone bound inside of the pocket had 
an interaction energy of -2.06 kcalmol-1. This confirms that the 
lowest energy conformations of each cathinone are truly indicative 
of the way they bind to probe 2 and are in good agreement with the 
experimentally observed data. 
 
Fig. 3. DFT fully optimized structure of probe 2 complexed with mephedrone 
highlighting the array of intermolecular interactions (-, CH, NHN and 
NHOC). 
 
In order to see how the chemosensor detected cathinones at 
low concentrations, the molecular probe’s photophysical properties 
using fluorescence spectroscopy were investigated. A 5  10-6 
moldm-3 acetone solution of probe 2 was prepared and excited at 
410 nm. The fluorescence spectrum of probe 2 showed a 
featureless band at 485 nm. Addition of neat mephedrone or 
flephedrone (freebase) produced significant changes to the 
fluorescence emission of probe 2 (Fig. 4; see ESI Fig. S27 for 
mephedrone). Aliquots of the drug were added to the acetone 
solution of probe 2. Addition of the first aliquot produced an 
increase in fluorescence intensity, which was a much larger increase 
for flephedrone than mephedrone. This is supported by the DFT 
calculations of the complexes; flephedrone forms a more stable  
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stacking arrangement with the anthracene moiety, due to the 
electron withdrawing nature of the fluorine group. This generates 
an initial fluorescence emission increase resulting from the exciplex 
(Fig. 4-insert). DFT studies indicate mephedrone prefers to bind 
inside the pocket and interact with the benzyl π systems, rather 
than the anthracene moiety. Additional aliquots resulted in 
sequential quenching of the system. 
Even though there were only modest optical changes upon the 
binding between probe 2 and mephedrone, the 1H-NMR spectra 
showed significant chemical shift changes with the drug and no 
changes with caffeine and benzocaine, two common cutting agents 
found in mephedrone street samples. Therefore, we used NMR 
spectroscopy to evaluate if probe 2 could be used to detect 
mephedrone in a simulated ‘street’ sample containing these two 
compounds. Therefore, a protocol was developed to produce the 
freebase of mephedrone in the presence of benzocaine and 
caffeine. Mephedrone hydrochloride, benzocaine and caffeine were 
combined in equal proportions and dissolved in water. The mixture 
was then filtered, as caffeine is sparingly soluble in water compared 
to benzocaine and mephedrone hydrochloride. The mephedrone 
freebase was then liberated with ammonium hydroxide (pH = 10) 
and extracted into diethyl ether. The NMR of this solution showed 
the presence of all compounds; however, reduced caffeine and 
benzocaine signals were seen relative to mephedrone, which was 
an advantageous consequence of the protocol. NMR titration of 
probe 2 against this extracted street sample mixture confirmed that 
mephedrone, indeed, still preferentially binds in the presence of 
caffeine and benzocaine (ESI Fig. S28 to S33). 
 
 
Fig. 4. Normalized fluorescent titration of probe 2 with neat flephedrone 
(red lines indicate probe 2 only and the first aliquot) Insert: Plot of 
flephedrone concentration and the quenching of fluorescence intensity at 
485 nm (acetone, 510-6 moldm-3, ex = 410 nm). 
 
In summary, an anthracene molecular ‘clip’ displayed greater 
interaction with mephedrone vs methamphetamine and other 
related analogues via 1H-NMR, suggesting a preference for a -
ketoamine arrangement. Interestingly, DFT calculations confirmed 
the NMR and fluorescence experimental results suggesting different 
binding geometries for mephedrone vs flephedrone. Addition of 
common cutting agents did not affect interaction between 
mephedrone and probe 2, which is promising for use with ‘street’ 
samples. The development of an in-field chemosensor is a 
continuing endeavour; however, significant knowledge about the 
structural components necessary to selectively bind mephedrone 
has been gained. 
Synthesis and characterization protocols are highlighted in the 
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